() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Fiscal Year 2018

WeedMD Reports Fiscal Year 2018 Financial Results

May 01, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report its financial results for the fourth quarter and fiscal year ending December 31, 2018.
Read more

Revive Therapeutics Ltd. Announces Results for Fiscal Year Ended June 30, 2018

Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Revive” or the “Company”), a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products, today announced its results for the fiscal year ended June 30, 2018.  The Audited Financial Statements and Management's Discussion and Analysis for the year ended June 30, 2018, may be viewed on SEDAR at www.sedar.com.
Read more

Cannabis Strategic Ventures Announces Completion of Fiscal Year 2018 Audit and Pursues Fully Reporting Status

Sept. 27, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- Cannabis Strategic Ventures, Inc. (OTC Pink: NUGS) is pleased to announce the completion of a full audit for its fiscal year ending March 31, 2018. This completes the three-year audit required as part of becoming a fully reporting company with the U.S. Securities & Exchange Commission (“SEC”). Cannabis Strategic Ventures will utilize the audit results to file future reports and disclosures with the SEC and move the Company to fully reporting status. The Company will also use the fully reporting status to uplist to a higher OTC Markets tier. 
Read more